Last reviewed · How we verify
NCT07252817
Intensive Monitoring of Post-surgery Pain in Major Ambulatory Surgery
NA trial testing Intensive monioring group in Hernioplasty in 280 participants. Completed in 15 August 2025.
5 August 2025
Quick facts
| Lead sponsor | Consorci Sanitari del Maresme |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 280 |
| Start date | 17 February 2025 |
| Primary completion | 5 August 2025 |
| Estimated completion | 15 August 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Intensive monioring group
- Standard monitoring group
Conditions studied
- Hernioplasty — all drugs for Hernioplasty →
- Cholecystectomy, Laparoscopic — all drugs for Cholecystectomy, Laparoscopic →
- Haemorrhoidal Surgery — all drugs for Haemorrhoidal Surgery →
- Knee Arthroscopy — all drugs for Knee Arthroscopy →
Sponsor
Consorci Sanitari del Maresme
Who can join
18 and older, any sex, with Hernioplasty or Cholecystectomy, Laparoscopic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Moderate to severe acute postoperative pain (APP) during part of the postoperative period is a barrier that hinders the central objective of perioperative medicine, which is to achieve an optimal postoperative recovery process. Despite advances in perioperative medicine, a large proportion of post-operative patients continue to suffer from moderate to severe APS during many of the days of their convalescence. This poor control of APS, in addition to causing suffering and exposing the patient to an increased risk of complications, could impair the quality of post-surgical recovery , according to some authors. We therefore consider it to be of utmost interest in our field to corroborate whether the implementation of measures to better control DAP is related to a better quality of post-surgical recovery. Currently, the growing trend to take into account the perspective of patients in their care has prompted the development of various patient-centred measurement tools that, among other aspects, assess the quality of post-surgical recovery. Several scales have been designed. The most widely used are the QoR-40, QoR-9 and QoR-15 scales. The latter, with a range of 0 to 150, was developed to simplify assessment, especially in telephone follow-ups, and has a reliability similar to its predecessor, the QoR-40.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07252817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Consorci Sanitari del Maresme trials
Trials by the same sponsor.
- NCT04519008 — Effectiveness and Security Testing of a Mobile App · NA · not yet recruiting
- NCT06925880 — Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Kn · NA · recruiting
- NCT06497426 — Efficacy of a Water Intervention in Institutionalized Aged Population. · NA · completed
- NCT06507098 — Effectiveness of Telematic Instruction to Patients in the Correct Performance of Respiratory Polygraphy at Home · NA · completed
- NCT06280586 — Effectiveness of Intervention in Prevention of Sarcopenia, Frailty and Functional Decline in Pre-frail Community Elderly · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07252817 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Consorci Sanitari del Maresme
- Last refreshed: 5 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07252817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing